Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Optimized Maintenance Study Treatment

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Apr 30, 2021 1:36pm

144 Views

Post# 33102208

RE:RE:Optimized Maintenance Study Treatment

Thanks for you great post Enrique. So informative.

I think I saw in an old thread that a family member of yours was a urologist. Is that correct? What does an industry insider (so to speak) think about the state of BCG unresponsive NMIBC? There is a ton of online excitement about SESN but all my reading suggests that it is treatment intensive and 12 CR is something like 17%.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 8, 2024)